3D Medicines, Inc. (HK:1244) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
3D Medicines Inc. has announced its intention to adopt a Chinese name to bolster its presence and corporate identity in the Greater China market, a move considered beneficial for future business development. Shareholders’ rights and the company’s financial position will remain unaffected by this change, and existing share certificates will continue to be valid. Additionally, the company has rescheduled its Annual General Meeting (AGM) to June 28, 2024, and will close its register of members for a short period around this date to determine attendee eligibility.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.